175 related articles for article (PubMed ID: 37084565)
1. Immediate hypersensitivity reactions to antineoplastic agents - A practical guide for the oncologist.
Seghers S; Teuwen LA; Beyens M; De Blick D; Sabato V; Ebo DG; Prenen H
Cancer Treat Rev; 2023 May; 116():102559. PubMed ID: 37084565
[TBL] [Abstract][Full Text] [Related]
2. Immediate Hypersensitivity Reaction to Chemotherapeutic Agents.
Giavina-Bianchi P; Patil SU; Banerji A
J Allergy Clin Immunol Pract; 2017; 5(3):593-599. PubMed ID: 28483313
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of immediate hypersensitivity reaction to paclitaxel-based chemotherapy in gynecologic cancer patients.
Thangwonglers T; Santimaleeworagun W; Therasakvichya S; Saengsukkasemsak N; Pimsi P
Asian Pac J Allergy Immunol; 2023 Dec; 41(4):340-346. PubMed ID: 33068367
[TBL] [Abstract][Full Text] [Related]
4. Management and preparedness for infusion and hypersensitivity reactions.
Lenz HJ
Oncologist; 2007 May; 12(5):601-9. PubMed ID: 17522249
[TBL] [Abstract][Full Text] [Related]
5. Immediate Hypersensitivity Reactions Caused by Drug Excipients: A Literature Review.
Caballero ML; Quirce S
J Investig Allergol Clin Immunol; 2020 Apr; 30(2):86-100. PubMed ID: 32327401
[TBL] [Abstract][Full Text] [Related]
6. Hypersensitivity reactions to chemotherapy: an EAACI Position Paper.
Pagani M; Bavbek S; Alvarez-Cuesta E; Berna Dursun A; Bonadonna P; Castells M; Cernadas J; Chiriac A; Sahar H; Madrigal-Burgaleta R; Sanchez Sanchez S
Allergy; 2022 Feb; 77(2):388-403. PubMed ID: 34587281
[TBL] [Abstract][Full Text] [Related]
7. Acute hypersensitivity reactions to chemotherapy agents: an overview.
Syrigou E; Triantafyllou O; Makrilia N; Kaklamanos I; Kotanidou A; Manolopoulos L; Syrigos K
Inflamm Allergy Drug Targets; 2010 Jul; 9(3):206-13. PubMed ID: 20632960
[TBL] [Abstract][Full Text] [Related]
8. Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancer.
Ruggiero A; Triarico S; Trombatore G; Battista A; Dell'acqua F; Rizzari C; Riccardi R
Eur J Clin Pharmacol; 2013 Oct; 69(10):1739-46. PubMed ID: 23765411
[TBL] [Abstract][Full Text] [Related]
9. Preparations of exploration of immediate hypersensitivity to antineoplastic agents: An oncology pharmacy perspective.
Dubromel A; Caffin AG; Hacard F; Vantard N; Baudouin A; Herledan C; Larbre V; Schwiertz V; Nosbaum A; Pralong P; Nicolas JF; Berard F; Rioufol C; Ranchon F
J Oncol Pharm Pract; 2022 Oct; 28(7):1552-1559. PubMed ID: 34546819
[TBL] [Abstract][Full Text] [Related]
10. Hypersensitivity reactions to antineoplastic agents: an overview.
Syrigou E; Makrilia N; Koti I; Saif MW; Syrigos KN
Anticancer Drugs; 2009 Jan; 20(1):1-6. PubMed ID: 19342995
[TBL] [Abstract][Full Text] [Related]
11. Immediate and delayed hypersensitivity reactions to intravascular iodine based radiocontrast media -- an update.
Bumbăcea RS; Petruţescu B; Bumbăcea D; Strâmbu I
Pneumologia; 2013; 62(1):47-51. PubMed ID: 23781574
[TBL] [Abstract][Full Text] [Related]
12. Diagnoses and Management of Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: Reactions to Taxanes and Monoclonal Antibodies.
Bonamichi-Santos R; Castells M
Clin Rev Allergy Immunol; 2018 Jun; 54(3):375-385. PubMed ID: 27277133
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity Reactions to Platinum Agents and Taxanes.
Tsao LR; Young FD; Otani IM; Castells MC
Clin Rev Allergy Immunol; 2022 Jun; 62(3):432-448. PubMed ID: 34338975
[TBL] [Abstract][Full Text] [Related]
14. Hypersensitivity reactions to non-steroidal anti-inflammatory drugs.
Cornejo-Garcia JA; Blanca-López N; Doña I; Andreu I; Agúndez JA; Carballo M; Blanca M; Canto MG
Curr Drug Metab; 2009 Nov; 10(9):971-80. PubMed ID: 20214589
[TBL] [Abstract][Full Text] [Related]
15. Review of hypersensitivity reactions to antineoplastic agents.
Cortijo-Cascajares S; Jiménez-Cerezo MJ; Herreros de Tejada A
Farm Hosp; 2012; 36(3):148-58. PubMed ID: 22484106
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic workup including CD203c-based basophil activation test in immediate hypersensitivity due to metronidazole and ornidazole and evaluation of cross-reactivity in between.
Beyaz Ş; Akdeniz N; Yılmaz A; Demir S; Öztop N; Çolakoğlu B; Büyüköztürk S; Deniz G; Gelincik A
Allergy; 2021 Mar; 76(3):842-852. PubMed ID: 32761620
[TBL] [Abstract][Full Text] [Related]
17. Acute infusion reactions to chemotherapeutic drugs: a single institute experience.
Muallaoglu S; Disel U; Mertsoylu H; Besen A; Karadeniz C; Taner Sumbul A; Abali H; Ozyilkan O
J BUON; 2013; 18(1):261-7. PubMed ID: 23613414
[TBL] [Abstract][Full Text] [Related]
18. Are antineoplastic drug acute hypersensitive reactions a submerged or an emergent problem? Experience of the Medical Day Hospital of the Fondazione IRCCS Istituto Nazionale Tumori.
Ferrari LA; Fanetti G; Rossi FG; Brambilla MC; Re B; Buzzoni R
Tumori; 2014; 100(1):9-14. PubMed ID: 24675484
[TBL] [Abstract][Full Text] [Related]
19. Retrospective study of hypersensitivity reactions to chemotherapeutic agents in a thoracic oncology service.
Capelle H; Tummino C; Greillier L; Gouitaa M; Birnbaum J; Ausias N; Barlesi F; Montana M
J Clin Pharm Ther; 2018 Jun; 43(3):320-326. PubMed ID: 29092096
[TBL] [Abstract][Full Text] [Related]
20. Clinical validation of the basophil activation test in immediate hypersensitivity reactions to gadolinium-based contrast agents.
Cabrera CM; Clarcast M; Palacios-Cañas A
Int Immunopharmacol; 2023 Apr; 117():110000. PubMed ID: 37012878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
